MedPath

Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis

Completed
Conditions
Severe Sepsis
Septic Shock
Interventions
Registration Number
NCT01332734
Lead Sponsor
Medical Centre Leeuwarden
Brief Summary

During infections (sepsis) bloodflow in small vessels (microcirculation) becomes disturbed. Restoration of bloodpressure and cardiac performance may not be sufficient to correct these alterations. Magnesium is a potent vasodilator which may be used to open up the small vessels, in order to reduce organ failure.

Detailed Description

In a single-center open label study we evaluated the effects of magnesium sulphate (MgS) infusion on the sublingual microcirculation perfusion in fluid resuscitated patients with severe sepsis and septic shock within the first 48 hours after ICU admission. Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • severe sepsis and septic shock
Exclusion Criteria
  • pregnancy
  • oral bleeding
  • age < 18 years
  • liver cirrhosis
  • acute arrhythmias
  • advanced malignancy or a mean arterial pressure (MAP) < 65 mmHg refractory to vasopressors

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
severe sepsis and septic shockMagnesium Sulfate-
Primary Outcome Measures
NameTimeMethod
microvascular flow index1 hour

Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital of Lithuanian university of health sciences

🇱🇹

Kaunas, Lithuania

© Copyright 2025. All Rights Reserved by MedPath